The Effect of a Disease Management Intervention on Quality and Outcomes of Dementia Care
Top Cited Papers
- 21 November 2006
- journal article
- research article
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 145 (10), 713-726
- https://doi.org/10.7326/0003-4819-145-10-200611210-00004
Abstract
Adherence to dementia guidelines is poor despite evidence that some guideline recommendations can improve symptoms and delay institutionalization of patients. To test the effectiveness of a dementia guideline–based disease management program on quality of care and outcomes for patients with dementia. Clinic-level, cluster randomized, controlled trial. 3 health care organizations collaborating with 3 community agencies in southern California. 18 primary care clinics and 408 patients with dementia age 65 years or older paired with 408 informal caregivers. Disease management program led by care managers and provided to 238 patient–caregiver pairs at 9 intervention clinics for more than 12 months. Adherence to 23 guideline recommendations (primary outcome) and receipt of community resources and patient and caregiver health and quality-of-care measures (secondary outcomes). The mean percentage of per-patient guideline recommendations to which care was adherent was significantly higher in the intervention group than in the usual care group (63.9% vs. 32.9%, respectively; adjusted difference, 30.1% [95% CI, 25.2% to 34.9%]; P < 0.001). Participants who received the intervention had higher care quality on 21 of 23 guidelines (P ≤ 0.013 for all), and higher proportions received community agency assistance (P ≤ 0.03) than those who received usual care. Patient health-related quality of life, overall quality of patient care, caregiving quality, social support, and level of unmet caregiving assistance needs were better for participants in the intervention group than for those in the usual care group (P < 0.05 for all). Caregiver health-related quality of life did not differ between the 2 groups. Participants were well-educated, were predominantly white, had a usual source of care, and were not institutionalized. Generalizability to other patients and geographic regions is unknown. Also, costs of a care management program under fee-for-service reimbursement may impede adoption. A dementia guideline–based disease management program led to substantial improvements in quality of care for patients with dementia. Current Controlled Trials identifier: ISRCTN72577751.Keywords
This publication has 32 references indexed in Scilit:
- The Quality of Medical Care Provided to Vulnerable Community-Dwelling Older PatientsAnnals of Internal Medicine, 2003
- Meta‐Analysis of Psychosocial Interventions for Caregivers of People with DementiaJournal of the American Geriatrics Society, 2003
- How Well Are Clinicians Following Dementia Practice Guidelines?Alzheimer Disease & Associated Disorders, 2002
- Practice parameter: Management of dementia (an evidence-based review) [RETIRED]Neurology, 2001
- Treatment of agitation in ADNeurology, 2000
- Lessons Learned from the Medicare Alzheimer Disease DemonstrationAlzheimer Disease & Associated Disorders, 2000
- Clinical Detection of Depression Among Community-Based Elderly People With Self-Reported Symptoms of DepressionThe Journals of Gerontology: Series A, 1998
- Risk factors for reported elder abuse and neglect: a nine-year observational cohort study.The Gerontologist, 1997
- Behavioral treatment of depression in dementia patients: a controlled clinical trial.The Journals of Gerontology, Series B: Psychological Sciences and Social Sciences, 1997
- A Randomized Trial of Family Caregiver Support in the Home Management of DementiaJournal of the American Geriatrics Society, 1990